Eli Lilly

                   

Corruption - Pharma $$, CMPI, MS&L, DrugWonks and the FDA

ahrp.blogspot.com     Aug 15, 2008          

The pharmaceutical industry's stealth influence peddling, directed toward healthcare professionals and the media, is carried out through public relations front groups who are bankrolled by drug manufacturers. For example,...                    

comments

Biotech incubator to launch its ninth company

nwsource.com     Aug 15, 2008          

Accelerator Corp., the Seattle-based biotech incubator, will start its ninth company Friday, in the ultimate hope of developing treatments that can effectively regulate the expression of genes and, therefore, prevent illness.                    

comments

FASB has drug makers squealing

soxfirst.com     Aug 15, 2008          

Big question marks hang over the latest proposals from the Financial Accounting Standards Board, reported here, requiring companies to account for the potential cost of ongoing litigation. As The Wall Street Journal points out,...                    

comments

                   

Zacks Analyst Blog Highlights: SGX Pharmaceuticals, Inc., Eli Lilly & Co., Petrobras, Sonic...

pharmiweb.co.uk     Aug 15, 2008   6 related          

Friday August 15, 6:00 am ET CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...                    

comments

ONN.tv Report: Eli Lilly (LLY) Pipeline for Alzheimer's Stands to Benefit from Aging Boomers

pharmiweb.co.uk     Aug 15, 2008          

Friday August 15, 10:06 am ET CHICAGO--(BUSINESS WIRE)--OptionsNews, the daily video news program on www.onn.tv , looks at expectations for expiration Friday, Kohl’s efforts to draw in shoppers, and the effect the tremendous...                    

comments

BioMS Medical announces positive interim analysis on Phase III dirucotide trial

pharmaceutical-business-review.com     Aug 15, 2008   15 related          

BioMS Medical has announced that the independent drug safety monitoring board for the Maestro-01 trial has conducted the scheduled interim analysis of efficacy and safety and has recommended that the trial continue to...                    

comments

SGX says proxy firms advise approval of Lilly bid

ibtimes.com     Aug 14, 2008   7 related          

SAN DIEGO - SGX Pharmaceuticals Inc. said Thursday that two proxy firms have advised its shareholders to vote in favor of Eli Lilly's $64 million buyout offer at a meeting later this month. Glass Lewis & Co. and Institutional...                    

comments

                   

UK's Protherics and Others in Europe Join M&A Parade

tmcnet.com     Aug 14, 2008          

The flurry of merger and acquisition activity this year has been targeted mostly at U.S. companies, but their European brethren aren't being overlooked, now including London-based Protherics plc. While U.S. biotechs have been...                    

comments

                   

Heroes in the Mental Health Field

vaservice.org     Aug 14, 2008          

Nominations are being accepted for "Heroes in the Fight." The program, which recognizes people making a difference in the fight against mental illness, is presented by Eli Lilly and Company and Voices, and co-sponsored by...                    

comments

                   

Lipid Sciences, Inc. Reports Financial Results for the Second Quarter 2008

tmcnet.com     Aug 14, 2008   14 related          

PLEASANTON, CA, August 14 / MARKET WIRE/ -- Lipid Sciences, Inc. (NASDAQ: LIPD) today reported financial results for the second quarter of 2008. Forward-Looking Statements: This release contains forward-looking statements...                    

comments